Trials / Completed
CompletedNCT05082428
This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.
Retrospective Non-interventional Multicenter Patient Chart Data Study on Tofacitinib Realworld Experience in Ulcerative Colitis in Finland (FinTofUC)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 252 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to describe and evaluate clinical outcomes, treatment lines, and to identify the key characteristics of the patients treated with tofacitinib.
Conditions
Timeline
- Start date
- 2022-05-30
- Primary completion
- 2022-11-01
- Completion
- 2022-11-01
- First posted
- 2021-10-19
- Last updated
- 2024-09-23
- Results posted
- 2024-09-23
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT05082428. Inclusion in this directory is not an endorsement.